Suppr超能文献

相似文献

1
Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.
Bioorg Med Chem. 2010 Sep 15;18(18):6771-5. doi: 10.1016/j.bmc.2010.07.050. Epub 2010 Jul 25.
2
Peptide HIV-1 integrase inhibitors from HIV-1 gene products.
J Med Chem. 2010 Jul 22;53(14):5356-60. doi: 10.1021/jm1003528.
3
Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.
ACS Chem Biol. 2013 Oct 18;8(10):2235-44. doi: 10.1021/cb400495h. Epub 2013 Aug 15.
6
HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence.
Molecules. 2018 Jul 26;23(8):1858. doi: 10.3390/molecules23081858.
7
Covalent Inhibition of HIV-1 Integrase by N-Succinimidyl Peptides.
ChemMedChem. 2016 Sep 20;11(18):1987-94. doi: 10.1002/cmdc.201600190. Epub 2016 Jun 22.
8
Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
FEBS Lett. 2008 Apr 30;582(10):1425-30. doi: 10.1016/j.febslet.2008.02.076. Epub 2008 Mar 10.
9
A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.
J Mol Biol. 2002 Apr 19;318(1):45-58. doi: 10.1016/S0022-2836(02)00033-5.

引用本文的文献

1
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins.
RSC Adv. 2023 Jan 12;13(3):2156-2167. doi: 10.1039/d2ra06837k. eCollection 2023 Jan 6.
2
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins.
Biomolecules. 2021 Feb 3;11(2):208. doi: 10.3390/biom11020208.
3
Development of peptide inhibitors of HIV transmission.
Bioact Mater. 2016 Sep 16;1(2):109-121. doi: 10.1016/j.bioactmat.2016.09.004. eCollection 2016 Dec.
4
Inhibiting the HIV integration process: past, present, and the future.
J Med Chem. 2014 Feb 13;57(3):539-66. doi: 10.1021/jm400674a. Epub 2013 Sep 25.
5
Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.
ACS Chem Biol. 2013 Oct 18;8(10):2235-44. doi: 10.1021/cb400495h. Epub 2013 Aug 15.
6
HIV integrase inhibitors: 20-year landmark and challenges.
Adv Pharmacol. 2013;67:75-105. doi: 10.1016/B978-0-12-405880-4.00003-2.

本文引用的文献

1
Peptide HIV-1 integrase inhibitors from HIV-1 gene products.
J Med Chem. 2010 Jul 22;53(14):5356-60. doi: 10.1021/jm1003528.
4
Raltegravir: a new antiretroviral class for salvage therapy.
Lancet. 2007 Apr 14;369(9569):1235-1236. doi: 10.1016/S0140-6736(07)60571-6.
5
Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
Arch Biochem Biophys. 2007 Feb 15;458(2):202-12. doi: 10.1016/j.abb.2006.12.007. Epub 2006 Dec 28.
6
Preferential inhibition of the magnesium-dependent strand transfer reaction of HIV-1 integrase by alpha-hydroxytropolones.
Mol Pharmacol. 2006 Apr;69(4):1454-60. doi: 10.1124/mol.105.020321. Epub 2006 Jan 17.
8
Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.
J Biol Chem. 2005 Jun 10;280(23):21987-96. doi: 10.1074/jbc.M414679200. Epub 2005 Mar 23.
9
Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins.
J Virol. 2004 May;78(10):5056-67. doi: 10.1128/jvi.78.10.5056-5067.2004.
10
NMR structure of the HIV-1 regulatory protein VPR.
J Mol Biol. 2003 Mar 14;327(1):215-27. doi: 10.1016/s0022-2836(03)00060-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验